BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 26271611)

  • 1. Comparison between Ki67 labeling index determined using image analysis software with virtual slide system and that determined visually in breast cancer.
    Maeda I; Abe K; Koizumi H; Nakajima C; Tajima S; Aoki H; Tsuchiya J; Tsuchiya S; Tsuchiya K; Shimo A; Tsugawa K; Ueno T; Tatsunami S; Takagi M
    Breast Cancer; 2016 Sep; 23(5):745-51. PubMed ID: 26271611
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Comparison of Visual Assessment and Automated Digital Image Analysis of Ki67 Labeling Index in Breast Cancer.
    Zhong F; Bi R; Yu B; Yang F; Yang W; Shui R
    PLoS One; 2016; 11(2):e0150505. PubMed ID: 26928407
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sequential immunohistochemistry and virtual image reconstruction using a single slide for quantitative KI67 measurement in breast cancer.
    Serna G; Simonetti S; Fasani R; Pagliuca F; Guardia X; Gallego P; Jimenez J; Peg V; Saura C; Eppenberger-Castori S; Ramon Y Cajal S; Terracciano L; Nuciforo P
    Breast; 2020 Oct; 53():102-110. PubMed ID: 32707454
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The region-of-interest size impacts on Ki67 quantification by computer-assisted image analysis in breast cancer.
    Christgen M; von Ahsen S; Christgen H; Länger F; Kreipe H
    Hum Pathol; 2015 Sep; 46(9):1341-9. PubMed ID: 26206765
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An interobserver reproducibility analysis of Ki67 visual assessment in breast cancer.
    Shui R; Yu B; Bi R; Yang F; Yang W
    PLoS One; 2015; 10(5):e0125131. PubMed ID: 25932921
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitative growth fraction evaluation with MIB1 and Ki67 antibodies in breast carcinomas.
    Barbareschi M; Girlando S; Mauri FM; Forti S; Eccher C; Mauri FA; Togni R; Dalla Palma P; Doglioni C
    Am J Clin Pathol; 1994 Aug; 102(2):171-5. PubMed ID: 8042584
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Practical approaches to automated digital image analysis of Ki-67 labeling index in 997 breast carcinomas and causes of discordance with visual assessment.
    Kwon AY; Park HY; Hyeon J; Nam SJ; Kim SW; Lee JE; Yu JH; Lee SK; Cho SY; Cho EY
    PLoS One; 2019; 14(2):e0212309. PubMed ID: 30785924
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Visual assessment of Ki67 at a glance is an easy method to exclude many luminal-type breast cancers from counting 1000 cells.
    Hida AI; Oshiro Y; Inoue H; Kawaguchi H; Yamashita N; Moriya T
    Breast Cancer; 2015 Mar; 22(2):129-34. PubMed ID: 23543399
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interobserver concordance of Ki67 labeling index in breast cancer: Japan Breast Cancer Research Group Ki67 ring study.
    Mikami Y; Ueno T; Yoshimura K; Tsuda H; Kurosumi M; Masuda S; Horii R; Toi M; Sasano H
    Cancer Sci; 2013 Nov; 104(11):1539-43. PubMed ID: 23905924
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reliability of Ki67 visual scoring app compared to eyeball estimate and digital image analysis and its prognostic significance in hormone receptor-positive breast cancer.
    Arun I; Venkatesh S; Ahmed R; Agrawal SK; Leung SCY
    APMIS; 2021 Aug; 129(8):489-502. PubMed ID: 34053140
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of tissue sampling on accuracy of Ki67 immunohistochemistry evaluation in breast cancer.
    Besusparis J; Plancoulaine B; Rasmusson A; Augulis R; Green AR; Ellis IO; Laurinaviciene A; Herlin P; Laurinavicius A
    Diagn Pathol; 2016 Aug; 11(1):82. PubMed ID: 27576949
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Digital image analysis of Ki67 proliferation index in breast cancer using virtual dual staining on whole tissue sections: clinical validation and inter-platform agreement.
    Koopman T; Buikema HJ; Hollema H; de Bock GH; van der Vegt B
    Breast Cancer Res Treat; 2018 May; 169(1):33-42. PubMed ID: 29349710
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proliferation assessment in breast carcinomas using digital image analysis based on virtual Ki67/cytokeratin double staining.
    Røge R; Riber-Hansen R; Nielsen S; Vyberg M
    Breast Cancer Res Treat; 2016 Jul; 158(1):11-19. PubMed ID: 27283833
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of tumor heterogeneity on the assessment of Ki67 labeling index in well-differentiated neuroendocrine tumors metastatic to the liver: implications for prognostic stratification.
    Yang Z; Tang LH; Klimstra DS
    Am J Surg Pathol; 2011 Jun; 35(6):853-60. PubMed ID: 21566513
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Visual assessment of Ki67 using a 5-grade scale (Eye-5) is easy and practical to classify breast cancer subtypes with high reproducibility.
    Hida AI; Bando K; Sugita A; Maeda T; Ueda N; Matsukage S; Nakanishi M; Kito K; Miyazaki T; Ohtsuki Y; Oshiro Y; Inoue H; Kawaguchi H; Yamashita N; Aogi K; Moriya T
    J Clin Pathol; 2015 May; 68(5):356-61. PubMed ID: 25673730
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An interobserver reproducibility analysis of size-set semiautomatic counting for Ki67 assessment in breast cancer.
    Wang YX; Wang YY; Yang CG; Bu H; Yang WT; Wang L; Xu WM; Zhao XL; Zhao WX; Li L; Song SL; Yang JL
    Breast; 2020 Feb; 49():225-232. PubMed ID: 31911370
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic potential of automated Ki67 evaluation in breast cancer: different hot spot definitions versus true global score.
    Robertson S; Acs B; Lippert M; Hartman J
    Breast Cancer Res Treat; 2020 Aug; 183(1):161-175. PubMed ID: 32572716
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A methodology to ensure and improve accuracy of Ki67 labelling index estimation by automated digital image analysis in breast cancer tissue.
    Laurinavicius A; Plancoulaine B; Laurinaviciene A; Herlin P; Meskauskas R; Baltrusaityte I; Besusparis J; Dasevicius D; Elie N; Iqbal Y; Bor C
    Breast Cancer Res; 2014; 16(2):R35. PubMed ID: 24708745
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The use of automated Ki67 analysis to predict Oncotype DX risk-of-recurrence categories in early-stage breast cancer.
    Thakur SS; Li H; Chan AMY; Tudor R; Bigras G; Morris D; Enwere EK; Yang H
    PLoS One; 2018; 13(1):e0188983. PubMed ID: 29304138
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A simple digital image analysis system for automated Ki67 assessment in primary breast cancer.
    Alataki A; Zabaglo L; Tovey H; Dodson A; Dowsett M
    Histopathology; 2021 Aug; 79(2):200-209. PubMed ID: 33590538
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.